001     179162
005     20240229145535.0
024 7 _ |a 10.1210/clinem/dgac171
|2 doi
024 7 _ |a pmid:35306566
|2 pmid
024 7 _ |a 0021-972X
|2 ISSN
024 7 _ |a 0368-1610
|2 ISSN
024 7 _ |a 1945-7197
|2 ISSN
024 7 _ |a 2578-7241
|2 ISSN
024 7 _ |a altmetric:125045083
|2 altmetric
037 _ _ |a DKFZ-2022-00512
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Dam, Veerle
|0 0000-0002-5982-232X
|b 0
245 _ _ |a Genetically determined reproductive aging and coronary heart disease: a bidirectional two-sample Mendelian Randomization.
260 _ _ |a Oxford
|c 2022
|b Oxford University Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1655905528_23457
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2022 Jun 16;107(7):e2952-e2961
520 _ _ |a Accelerated reproductive aging, in women indicated by early natural menopause, is associated with increased coronary heart disease (CHD) risk in observational studies. Conversely, an adverse CHD risk profile has been suggested to accelerate menopause.To study the direction and evidence for causality of the relationship between reproductive aging and (non-)fatal CHD and CHD risk factors in a bidirectional Mendelian Randomization (MR) approach, using age at natural menopause (ANM) genetic variants as a measure for genetically determined reproductive aging in women. We also studied the association of these variants with CHD risk (factors) in men.Two-sample MR, using both cohort data as well as summary statistics, with four methods: simple and weighted median-based, standard inverse-variance weighted (IVW) regression, and MR-Egger regression.Data from EPIC-CVD and summary statistics from UK Biobank and publicly available GWAS were pooled for the different analyses.CHD, CHD risk factors and ANM.Across different methods of MR no association was found between genetically determined reproductive aging and CHD risk in women (Relative Risk Estimate (RRE)IVW=0.99, 95% confidence interval (CI):0.97;1.01), or any of the CHD risk factors. Similarly, no associations were found in men. Neither did the reversed analyses show evidence for an association between CHD (risk factors) and reproductive aging.Genetically determined reproductive aging is not causally associated with CHD risk (factors) in women, nor were the genetic variants associated in men. We found no evidence for a reverse association in a combined sample of women and men.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Mendelian Randomization
|2 Other
650 _ 7 |a Reproductive aging
|2 Other
650 _ 7 |a coronary heart disease
|2 Other
650 _ 7 |a risk factors
|2 Other
700 1 _ |a Onland-Moret, N Charlotte
|b 1
700 1 _ |a Burgess, Stephen
|0 0000-0001-5365-8760
|b 2
700 1 _ |a Chirlaque, Maria-Dolores
|0 0000-0001-9242-3040
|b 3
700 1 _ |a Peters, Sanne A E
|b 4
700 1 _ |a Schuit, Ewoud
|0 0000-0002-9548-3214
|b 5
700 1 _ |a Tikk, Kaja
|0 P:(DE-He78)eabbefb821cdb73961a5adf967330b62
|b 6
700 1 _ |a Weiderpass, Elisabete
|0 0000-0003-2237-0128
|b 7
700 1 _ |a Oliver-Williams, Clare
|b 8
700 1 _ |a Wood, Angela M
|b 9
700 1 _ |a Tjønneland, Anne
|b 10
700 1 _ |a Dahm, Christina C
|b 11
700 1 _ |a Overvad, Kim
|0 0000-0001-6429-7921
|b 12
700 1 _ |a Boutron-Ruault, Marie-Christine
|0 0000-0002-5956-5693
|b 13
700 1 _ |a Schulze, Matthias B
|b 14
700 1 _ |a Trichopoulou, Antonia
|0 0000-0002-7204-6396
|b 15
700 1 _ |a Ferrari, Pietro
|0 0000-0001-9358-7338
|b 16
700 1 _ |a Masala, Giovanna
|0 0000-0002-5758-9069
|b 17
700 1 _ |a Krogh, Vittorio
|0 0000-0003-0122-8624
|b 18
700 1 _ |a Tumino, Rosario
|b 19
700 1 _ |a Matullo, Giuseppe
|b 20
700 1 _ |a Panico, Salvatore
|0 0000-0002-5498-8312
|b 21
700 1 _ |a Boer, Jolanda M A
|b 22
700 1 _ |a Verschuren, W M Monique
|b 23
700 1 _ |a Waaseth, Marit
|b 24
700 1 _ |a Sánchez Pérez, Maria José
|b 25
700 1 _ |a Amiano, Pilar
|b 26
700 1 _ |a Imaz, Liher
|b 27
700 1 _ |a Moreno-Iribas, Conchi
|b 28
700 1 _ |a Melander, Olle
|b 29
700 1 _ |a Harlid, Sophia
|0 0000-0001-8540-6891
|b 30
700 1 _ |a Nordendahl, Maria
|b 31
700 1 _ |a Wennberg, Patrik
|b 32
700 1 _ |a Key, Timothy J
|b 33
700 1 _ |a Riboli, Elio
|0 0000-0001-6795-6080
|b 34
700 1 _ |a Santiuste, Carmen
|b 35
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 36
|u dkfz
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 37
|u dkfz
700 1 _ |a Langenberg, Claudia
|b 38
700 1 _ |a Wareham, Nicholas J
|b 39
700 1 _ |a Schunkert, Heribert
|0 0000-0001-6428-3001
|b 40
700 1 _ |a Erdmann, Jeanette
|b 41
700 1 _ |a Willenborg, Christina
|b 42
700 1 _ |a Hengstenberg, Christian
|0 0000-0002-8284-2994
|b 43
700 1 _ |a Kleber, Marcus E
|0 0000-0003-0663-7275
|b 44
700 1 _ |a Delgado, Graciela
|b 45
700 1 _ |a März, Winfried
|b 46
700 1 _ |a Kanoni, Stavroula
|b 47
700 1 _ |a Dedoussis, George
|b 48
700 1 _ |a Deloukas, Panos
|0 0000-0001-9251-070X
|b 49
700 1 _ |a Nikpay, Majid
|0 0000-0003-0285-6454
|b 50
700 1 _ |a McPherson, Ruth
|0 0000-0002-9087-6107
|b 51
700 1 _ |a Scholz, Markus
|0 0000-0002-4059-1779
|b 52
700 1 _ |a Teren, Andrej
|b 53
700 1 _ |a Butterworth, Adam S
|b 54
700 1 _ |a van der Schouw, Yvonne T
|b 55
773 _ _ |a 10.1210/clinem/dgac171
|g p. dgac171
|0 PERI:(DE-600)2026217-6
|n 7
|p e2952-e2961
|t The journal of clinical endocrinology & metabolism
|v 107
|y 2022
|x 0021-972X
909 C O |p VDB
|o oai:inrepo02.dkfz.de:179162
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)eabbefb821cdb73961a5adf967330b62
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 36
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 37
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-30
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-17
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J CLIN ENDOCR METAB : 2021
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-17
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J CLIN ENDOCR METAB : 2021
|d 2022-11-17
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 1
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21